Buyer for a non – clinical CRO in Europe

Company to buy

• Size: medium-sized business
• Revenue: 3-100 M EUR
• Location of the target company: Europe
• Reason for acquisition: The company wants to expand in the Europe and acquire a non – clinical CRO (contract research organization).
• #CFIE PHB026 

 Overview of the non – clinical CRO unit wanted

The buyer is interested to acquire a non – clinical CRO in the Europe that is under running conditions and has a revenue between 3 -100 million euro.

Profile (strategy) of the non – clinical CRO buyer   

This buyer is a well-known American company that is on the market for more than 70 years and makes several mergers every year.

The company specializes on pre-clinical, clinical and laboratory services for the pharmaceutical, medical device and biotechnology industries and supplies pharmaceutical companies with biomedical products and R&D outsourcing services.

It has a wide network among pharmaceutical companies worldwide and has kept a sustainable relationship with its client such as: pharmaceutical and biotechnology company, major academic institutions and government research centers.

Activities and products of the target non – clinical CRO unit

The goal of the buyer is to acquire a contract research organization (CRO) that operates on a non – clinical stage in Europe. 

Has a yearly turnover between 3-100 million euro, comply with all necessary GMP documents and would help to add capacity, research models, global footprint, regional expertise, logistics, professional consultancy and expertise for discovery and non-clinical drug development.

Highlights of the non – clinical CRO buyer

• A well known US biotechnlogy company that specializes on pre-clinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries. 
• Wants to acquire a non clinical contract research organization in Europe which would add capacity and would assist with research models, global footprint, regional expertise, regulatory requirements, logistics, professional consultancy and expertise for discovery and non-clinical drug development.
• The target should be a pharma packaging solution company with the revenue between (3 – 100 million eur).
• The buyer is a leading contract research organization and pharmaceutical company which specializes on early stage drug development for the life science industry.

Information about this buyer of non – clinical CRO  

Feel free to contact us for more information regarding this buyer of non – clinical CRO wanted in Europe or if you know possible interested or suited parties. For more buyers of pharmaceutical companies, please visit the section pharmaceutical companies wanted. For more sellers please visit the section pharmaceutical companies for sale.

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.